Literature DB >> 2327466

Leiomyosarcoma in a series of hysterectomies performed for presumed uterine leiomyomas.

S Leibsohn1, G d'Ablaing, D R Mishell, J B Schlaerth.   

Abstract

The incidence of leiomyosarcoma in uterine leiomyomas is estimated to be between 0.13 to 0.29%. However, the exact incidence of leiomyosarcoma in uteri removed with a preoperative diagnosis of benign uterine leiomyomas has not been previously reported. Between 1983 and 1988, a total of 1432 patients in Women's Hospital, a self-referred indigent population, had a hysterectomy planned because of abnormal uterine bleeding or abdominal pain associated with the presence of uterine leiomyomas, or because of a pelvic mass thought to be uterine leiomyoma of sufficient size or character to warrant surgical exploration. The ages of these women ranged from 36 to 62 years and the presence of leiomyosarcoma in the hysterectomy specimens increased steadily from the fourth to seventh decades of age (0.2%, 0.9%, 1.4%, and 1.7%, respectively). Preoperative histologic examination of the endometrium was performed in eight patients. Three of the eight patients had a preoperative tissue diagnosis of leiomyosarcoma that was clinically confined to the uterus. After the hysterectomy in the 1429 patients with presumed benign disease, histologic diagnosis of leiomyosarcoma was made in seven (0.49%). There was no evidence of malignancy in the endometrial sampling of any of these seven patients and the diagnosis was suspected intraoperatively in only three. Preoperative uterine size ranged from 8 to 20 weeks' gestational size and postoperative uterine weight ranged from 120 to 1100 gm. Seven of the 10 patients had symptoms of abnormal uterine bleeding. Between the ages of 40 and 60 years, 1% (8 of 817) of women with presumed uterine leiomyomas producing symptoms that necessitated hysterectomy in this series had leiomyosarcoma diagnosis postoperatively. Such treatments as gonadotropin-releasing hormone agonists, endometrial ablation, myomectomy by hysteroscopy or laparotomy instead of hysterectomy in such women could delay the diagnosis and definitive treatment of leiomyosarcoma.

Entities:  

Mesh:

Year:  1990        PMID: 2327466     DOI: 10.1016/0002-9378(90)91298-q

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  54 in total

Review 1.  A review of treatment of uterine leiomyosarcomas.

Authors:  Nicholas Reed
Journal:  Curr Oncol Rep       Date:  2013-12       Impact factor: 5.075

2.  Laparoscopic hysterectomy of large uteri using three-trocar technique.

Authors:  Wenjie Zeng; Liyou Chen; Weijie Du; Jinghui Hu; Xiangming Fang; Xiaofeng Zhao
Journal:  Int J Clin Exp Med       Date:  2015-04-15

3.  Cost-Effectiveness of Laparoscopic Hysterectomy With Morcellation Compared With Abdominal Hysterectomy for Presumed Myomas.

Authors:  Sarah E Rutstein; Matthew T Siedhoff; Elizabeth J Geller; Kemi M Doll; Jennifer M Wu; Daniel L Clarke-Pearson; Stephanie B Wheeler
Journal:  J Minim Invasive Gynecol       Date:  2015-10-22       Impact factor: 4.137

4.  Malignant transformation of leiomyoma of uterus to leiomyosarcoma with metastasis to ovary.

Authors:  Bhavana Madhukar Bharambe; Kalpana A Deshpande; Sanjay G Surase; Alkesh P Ajmera
Journal:  J Obstet Gynaecol India       Date:  2012-10-05

5.  Systemic Treatment of Metastatic/Recurrent Uterine Leiomyosarcoma: A Changing Paradigm.

Authors:  Rebecca C Arend; Michael D Toboni; Allison M Montgomery; Robert A Burger; Alexander B Olawaiye; Bradley J Monk; Thomas J Herzog
Journal:  Oncologist       Date:  2018-08-23

Review 6.  A critical assessment of morcellation and its impact on gynecologic surgery and the limitations of the existing literature.

Authors:  Fong W Liu; Valerie B Galvan-Turner; Krista S Pfaendler; Teresa C Longoria; Robert E Bristow
Journal:  Am J Obstet Gynecol       Date:  2015-01-09       Impact factor: 8.661

7.  Age-stratified risk of unexpected uterine sarcoma following surgery for presumed benign leiomyoma.

Authors:  Andrew S Brohl; Li Li; Vaagn Andikyan; Sarah G Običan; Angela Cioffi; Ke Hao; Joel T Dudley; Charles Ascher-Walsh; Andrew Kasarskis; Robert G Maki
Journal:  Oncologist       Date:  2015-03-12

8.  Radiological appearances of uterine fibroids.

Authors:  Sue Wilde; Sarah Scott-Barrett
Journal:  Indian J Radiol Imaging       Date:  2009 Jul-Sep

9.  Perforated intestinal leiomyosarcoma as a metastasis of uterine leiomyosarcoma: a case report.

Authors:  Bariş Saylam; Omer Vefik Ozozan; Arife Polat Düzgün; Bahadir Külah; Ozge Han; Faruk Coşkun
Journal:  Cases J       Date:  2009-09-17

Review 10.  Treatment of early uterine sarcomas: disentangling adjuvant modalities.

Authors:  Flora Zagouri; Athanasios-Meletios Dimopoulos; Stelios Fotiou; Vassilios Kouloulias; Christos A Papadimitriou
Journal:  World J Surg Oncol       Date:  2009-04-08       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.